Chronic daily headaches can be a difficult problem in children as well as adults. Over half of the cases of chronic daily headaches in adults are thought to be due to medication-overuse headache ...

Fremanezumab is safe, effective, and tolerable for children and adolescents with episodic migraine, reducing monthly migraine days.

The Nerivio® REN wearable provides a clinically proven, drug-free solution for both acute and preventive treatment of migraine in adults and children aged 8 and older.

Dextenza is an intracanalicular insert that delivers a 0.4mg dose of dexamethasone, a corticosteroid, for up to 30 days following insertion.

“Our results reinforce that hydroxyurea, the most efficacious medicine available for sickle cell disease, continues to have ...

The FDA has expanded the approval of Dextenza (dexamethasone ophthalmic insert) to include pediatric treatment.